Metabolism and Target Organ Damage

A Special Interview with Prof. Kezhong Zhang

Prof. Kezhong Zhang from the Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, MI, USA.

Congratulations! Metabolism and Target Organ Damage Achieves a First CiteScore of 3.0

CiteScore, a metric provided by Elsevier, gauges the average number of citations garnered per document published in a journal over a four-year span.

Introducing our new preprint platform, a fast and efficient way to share your research with the academic community.

We consistently welcome suggestions for improvements from both readers and authors (send an e-mail to preprint@scierxiv.com).

A Special Interview with Prof. Vincent Wai Sun Wong

Professor and Head, Division of Gastroenterology and Hepatology, The Chinese University of Hong Kong, Hong Kong, China.

Special Issue: Liver Fibrosis in Metabolic Dysfunction: Cellular and Molecular Mechanisms, Innovative Diagnostics, and Emerging Therapeutic Approaches

Given the increasing impact of liver fibrosis on clinical workload and health care costs worldwide, this Special Issue focuses specifically on liver fibrosis resulting from metabolic dysfunction.

Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality

Metabolic primary liver cancer in adults: risk factors and pathogenic mechanisms

Articles

Most Recent | Most Viewed | Most Downloaded

Perspective article: determinants and assessment of cardiovascular risk in steatotic liver disease owing to metabolic dysfunction-addressing the challenge

Mohamad Jamalinia

, Amedeo Lonardo

Open Access Perspective DOI: 10.20517/mtod.2024.34 25 Jun 2024

Views: Downloads:

Download PDF

Obesity and diabetes in heart disease in women

Yetunde A. Fatade, ... Puja K. Mehta

Open Access Review DOI: 10.20517/mtod.2023.30 16 Jun 2024

Views: Downloads:

Download PDF

Lower hepatic CBS and PEMT expression in advanced NAFLD: inferencing strategies to lower homocysteine with a mathematical model

Ayako Suzuki

, ... Manal F. Abdelmalek

Open Access Original Article DOI: 10.20517/mtod.2024.16 29 May 2024

Views: Downloads:

Download PDF

Could controversies in the arena of fatty liver disease be a potential gate for the democratization of science?

Yasser Fouad, ... Amedeo Lonardo

Open Access Perspective DOI: 10.20517/mtod.2024.26 28 May 2024

Views: Downloads:

Download PDF

Prevention and treatment of type 1 diabetes: in search of the ideal combination therapy targeting multiple immunometabolic pathways

Marcelo Maia Pinheiro

, ... Marco Infante

Open Access Commentary DOI: 10.20517/mtod.2024.12 15 May 2024

Views: Downloads:

Download PDF

Most Cited Papers In Last Two Years

Effect of cofactors on NAFLD/NASH and MAFLD - a paradigm illustrating the pathomechanics of organ dysfunction

Amedeo Lonardo

, ... Kusum K. Kharbanda

Open Access Perspective DOI: 10.20517/mtod.2022.14 21 Aug 2022

Views: Downloads:

Download PDF

Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality

Stefano Ballestri

, ... Amedeo Lonardo

Open Access Review DOI: 10.20517/mtod.2022.23 30 Jan 2023

Views: Downloads:

Download PDF

Concise review: gamma-glutamyl transferase - evolution from an indiscriminate liver test to a biomarker of cardiometabolic risk

Amedeo Lonardo

, Gjin Ndrepepa

Open Access Review DOI: 10.20517/mtod.2022.20 29 Sep 2022

Views: Downloads:

Download PDF

Webinars

Ongoing Special Issues

Topic: Hypertension and Metabolic Disorders: Pathophysiology, Clinical Management, and Novel Therapeutic Approaches

Prof. Xingjiang Xiong; Prof. Pengqian Wang; Prof. Wei Liu; Dr. Lian Duan

Submission Deadline: 31 Mar 2025

Published articles: 0

Topic: Mitochondrial Bioenergetics in Metabolic Diseases

Dr. Ayman Moawad Mahmoud; Dr. Chen Li

Submission Deadline: 31 Jan 2025

Published articles: 0

Editorial Board

Partners

Data

320

Authors

227

Reviewers

Articles

On Board Editors

2021

Published Since

For Authors

For Reviewers

Peer Review Guidelines

For Readers

Add your e-mail address to receive forthcoming Issues of this journal:

Topics Collection

Topic: Organ Dysfunction in Metabolic-Associated Fatty Liver Disease: Effect of Cofactors

Topic: The Latest Research Progress of Nonalcoholic Fatty Liver Disease

Topic: The Complications of Diabetes

Latest Issue

All Issues

Volume 4, Issue 3 (in progress)

Congratulations! Metabolism and Target Organ Damage Achieves a First CiteScore of 3.0

Announcement: Metabolism and Target Organ Damage Best Guest Editor Award 2024

A Special Interview with Prof. Kezhong Zhang

Prof. Kezhong Zhang from the Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, MI, USA.

Congratulations! Metabolism and Target Organ Damage Achieves a First CiteScore of 3.0

CiteScore, a metric provided by Elsevier, gauges the average number of citations garnered per document published in a journal over a four-year span.

Introducing our new preprint platform, a fast and efficient way to share your research with the academic community.

We consistently welcome suggestions for improvements from both readers and authors (send an e-mail to preprint@scierxiv.com).

A Special Interview with Prof. Vincent Wai Sun Wong

Professor and Head, Division of Gastroenterology and Hepatology, The Chinese University of Hong Kong, Hong Kong, China.

Special Issue: Liver Fibrosis in Metabolic Dysfunction: Cellular and Molecular Mechanisms, Innovative Diagnostics, and Emerging Therapeutic Approaches

Given the increasing impact of liver fibrosis on clinical workload and health care costs worldwide, this Special Issue focuses specifically on liver fibrosis resulting from metabolic dysfunction.

Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality

Metabolic primary liver cancer in adults: risk factors and pathogenic mechanisms

Webinars

Ongoing Special Issues

Topic: Hypertension and Metabolic Disorders: Pathophysiology, Clinical Management, and Novel Therapeutic Approaches

Prof. Xingjiang Xiong; Prof. Pengqian Wang; Prof. Wei Liu; Dr. Lian Duan

Submission Deadline: 31 Mar 2025

Published articles: 0

Topic: Mitochondrial Bioenergetics in Metabolic Diseases

Dr. Ayman Moawad Mahmoud; Dr. Chen Li

Submission Deadline: 31 Jan 2025

Published articles: 0

News

Congratulations! Metabolism and Target Organ Damage Achieves a First CiteScore of 3.0

Announcement: Metabolism and Target Organ Damage Best Guest Editor Award 2024

Data

320

Authors

227

Reviewers

Articles

On Board Editors

2021

Published Since

Metabolism and Target Organ Damage

Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality

Metabolic primary liver cancer in adults: risk factors and pathogenic mechanisms

Articles

Perspective article: determinants and assessment of cardiovascular risk in steatotic liver disease owing to metabolic dysfunction-addressing the challenge

Obesity and diabetes in heart disease in women

Lower hepatic CBS and PEMT expression in advanced NAFLD: inferencing strategies to lower homocysteine with a mathematical model

Could controversies in the arena of fatty liver disease be a potential gate for the democratization of science?

Prevention and treatment of type 1 diabetes: in search of the ideal combination therapy targeting multiple immunometabolic pathways

Effect of cofactors on NAFLD/NASH and MAFLD - a paradigm illustrating the pathomechanics of organ dysfunction

Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality

Concise review: gamma-glutamyl transferase - evolution from an indiscriminate liver test to a biomarker of cardiometabolic risk

Topic: Hypertension and Metabolic Disorders: Pathophysiology, Clinical Management, and Novel Therapeutic Approaches

Topic: Mitochondrial Bioenergetics in Metabolic Diseases

Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality

Metabolic primary liver cancer in adults: risk factors and pathogenic mechanisms

Topic: Hypertension and Metabolic Disorders: Pathophysiology, Clinical Management, and Novel Therapeutic Approaches

Topic: Mitochondrial Bioenergetics in Metabolic Diseases

Congratulations! Metabolism and Target Organ Damage Achieves a First CiteScore of 3.0

Announcement: Metabolism and Target Organ Damage Best Guest Editor Award 2024

Committee on Publication Ethics

Portico

Committee on Publication Ethics

Portico